COP LEY 114 (Procainamide SR 750 mg)
Pill imprint COP LEY 114 has been identified as Procainamide hydrochloride SR 750 mg.
Procainamide is used in the treatment of arrhythmia; myotonia congenita and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Procainamide 750 mg is not a controlled substance under the Controlled Substance Act (CSA).
Procainamide hydrochloride SR
- Imprint:
- COP LEY 114
- Strength:
- 750 mg
- Color:
- Orange
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
More about procainamide
Consumer resources
- Procainamide
- Procainamide capsules
- Procainamide controlled-release
- Procainamide injection
- Procainamide Intravenous (Advanced Reading)
- Other brands: Pronestyl, Procanbid, Pronestyl-SR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
